Eli Lilly (LLY) stock is in focus after the company reported better-than-expected results and issued a strong outlook. Bristol-Myers Squibb (BMY) shares are under pressure after the company ...
The fourth-quarter earnings season for the drug and biotech sector will be in full swing this week with many large drugmakers like — Merck, Pfizer, Eli Lilly and Co., Amgen and Bristol Myers ...
Per the Zacks classification, the pharma/biotech industry falls under the broader Medical sector, comprising pharma/biotech and generic companies, and medical device companies. Per the Earnings ...
Actress Lily Collins has made the surprising announcement that she's now a proud parent. The 35-year-old Emily in Paris star took to Instagram on Friday night alongside her husband, film director ...
RR Henry received grant support as the Principal Investigator for Bristol Myers Squibb/AstraZeneca, Johnson & Johnson/Janssen, Eli Lilly, Sanofi-aventis and Medtronics. He is on the advisory board ...
Bob Lilly had been a staple along the Dallas Cowboys defensive line for over a decade, and he was hoping that Super Bowl VI would be his time to finally win a championship. The Cowboys had fallen ...
But Aust services, in South Gloucestershire, has had a special place in the culture of Bristol and the West Country, ever since it served its first sausage and chips and heard its first gasped ...
Shares rise nearly 5% after upbeat forecast Drugmaker suggests demand for Zepbound and Mounjaro remains strong Lilly forecast earnings of $22.50 to $24.00 per share on an adjusted basis this year ...
For nearly a decade, Eli Lilly has been operating a global capability ... Other companies with GCCs in Hyderabad include Bristol Myers Squibb, Roche, Bayer, Amgen, Thermo Fisher Scientific and ...
Lilly is one of a handful of Big Pharmas that secured a close look at Mediar through venture investments. Bristol Myers Squibb, Lilly, Novartis Venture Fund, Ono Venture Investment and Pfizer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results